Biohaven Ltd.
US ˙ NYSE ˙ VGG1110E1079

SecurityBHVN / Biohaven Ltd.
InstitutionCitigroup Inc
Latest Disclosed Ownership35,237 shares
Latest Disclosed Value $ 298,105
Citigroup Inc ownership in BHVN / Biohaven Ltd.

On May 11, 2026 - Citigroup Inc filed a 13F-HR form disclosing ownership of 35,237 shares of Biohaven Ltd. (US:BHVN) valued at $298,105 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 29,125 shares of Biohaven Ltd.. This represents a change in shares of 20.99% during the quarter. The current value of the position is $380,912 USD.

Citigroup Inc has a history of taking positions in derivatives of the underlying security (BHVN) in the form of stock options.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

BHVN / Biohaven Ltd. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F BIOHAVEN COM G1110E107 35,237 6,112 20.99 298 -9.15 0.0001
2026-02-13 2025-12-31 13F BIOHAVEN COM G1110E107 29,125 14,163 94.66 329 46.43 0.0001
2025-11-10 2025-09-30 13F BIOHAVEN COM G1110E107 14,962 -215,669 -93.51 225 -93.12 0.0001
2025-08-11 2025-06-30 13F BIOHAVEN COM G1110E107 230,631 -40,365 -14.90 3,254 -50.05 0.0016
2025-05-12 2025-03-31 13F BIOHAVEN COM G1110E107 270,996 77,236 39.86 6,515 -9.98 0.0033
2025-02-12 2024-12-31 13F BIOHAVEN COM G1110E107 193,760 73,855 61.59 7,237 20.78 0.0043
2024-11-12 2024-09-30 13F BIOHAVEN COM G1110E107 119,905 66,801 125.79 5,992 225.07 0.0035
2024-08-12 2024-06-30 13F BIOHAVEN COM G1110E107 53,104 -112,396 -67.91 1,843 -79.64 0.0012
2024-05-10 2024-03-31 13F BIOHAVEN COM G1110E107 165,500 50,747 44.22 9,051 84.30 0.0059
2024-02-09 2023-12-31 13F BIOHAVEN COM G1110E107 114,753 -32,154 -21.89 4,911 28.53 0.0035
2023-12-06 2023-09-30 13F/A-1 BIOHAVEN COM G1110E107 146,907 72,673 97.90 3,821 115.27 0.0029
2023-11-09 2023-09-30 13F BIOHAVEN COM G1110E107 146,907 72,673 3,821 0.0011
2023-08-10 2023-06-30 13F BIOHAVEN COM G1110E107 74,234 -214,121 -74.26 1,776 -54.93 0.0012
2023-05-11 2023-03-31 13F BIOHAVEN COM G1110E107 288,355 125,878 77.47 3,939 74.63 0.0028
2023-02-09 2022-12-31 13F BIOHAVEN COM G1110E107 162,477 -198,599 -55.00 2,255 -95.87 0.0018
2022-11-10 2022-09-30 13F BIOHAVEN PHARMACTL HLDG CO L COM G11196105 361,076 315,276 688.38 54,584 717.86 0.0391
2022-11-10 2022-09-30 13F BIOHAVEN COM G1110E107 139,997 882
2022-08-10 2022-06-30 13F BIOHAVEN PHARMACTL HLDG CO L COM G11196105 45,800 28,790 169.25 6,674 230.89 0.0050
2022-05-12 2022-03-31 13F BIOHAVEN PHARMACTL HLDG CO L COM G11196105 17,010 -47,425 -73.60 2,017 -77.29 0.0012
2022-02-10 2021-12-31 13F BIOHAVEN PHARMACTL HLDG CO L COM G11196105 64,435 5,822 9.93 8,880 9.06 0.0048
2021-11-10 2021-09-30 13F BIOHAVEN PHARMACTL HLDG CO L COM G11196105 58,613 10,717 22.38 8,142 75.06 0.0048
2021-08-10 2021-06-30 13F BIOHAVEN PHARMACTL HLDG CO L COM G11196105 47,896 -19,267 -28.69 4,651 1.33 0.0028
2021-05-13 2021-03-31 13F BIOHAVEN PHARMACTL HLDG CO L COM G11196105 67,163 52,320 352.49 4,590 260.57 0.0030
2021-02-11 2020-12-31 13F BIOHAVEN PHARMACTL HLDG CO L COM G11196105 14,843 8,580 137.00 1,273 212.78 0.0008
2020-11-12 2020-09-30 13F BIOHAVEN PHARMACTL HLDG CO L COM G11196105 6,263 -29,062 -82.27 407 -84.24 0.0003
2020-08-12 2020-06-30 13F BIOHAVEN PHARMACTL HLDG CO L COM G11196105 35,325 -2,390 -6.34 2,582 101.25 0.0020
2020-05-12 2020-03-31 13F BIOHAVEN PHARMACTL HLDG CO L COM G11196105 37,715 24,546 186.39 1,283 78.94 0.0012
2020-02-12 2019-12-31 13F BIOHAVEN PHARMACTL HLDG CO L COM G11196105 13,169 -7,804 -37.21 717 -18.06 0.0005
2019-11-08 2019-09-30 13F BIOHAVEN PHARMACTL HLDG CO L COM G11196105 20,973 -45,325 -68.37 875 -69.87 0.0007
2019-08-12 2019-06-30 13F BIOHAVEN PHARMACTL HLDG CO L COM G11196105 66,298 59,882 933.32 2,904 780.00 0.0023
2019-05-13 2019-03-31 13F BIOHAVEN PHARMACTL HLDG CO L COM G11196105 6,416 -86,445 -93.09 330 -90.39 0.0003
2019-02-12 2018-12-31 13F BIOHAVEN PHARMACTL HLDG CO L COM G11196105 92,861 26,019 38.93 3,434 36.81 0.0035
2018-11-13 2018-09-30 13F BIOHAVEN PHARMACTL HLDG CO L COM G11196105 66,842 29,436 78.69 2,510 69.71 0.0022
2018-08-10 2018-06-30 13F BIOHAVEN PHARMACTL HLDG CO L COM G11196105 37,406 37,244 22,990.12 1,479 36,875.00 0.0014
2018-05-11 2018-03-31 13F BIOHAVEN PHARMACTL HLDG CO L COM G11196105 162 -6 -3.57 4 -20.00 0.0000
2018-02-12 2017-12-31 13F BIOHAVEN PHARMACTL HLDG CO L COM G11196105 168 168 5 0.0000
2017-11-13 2017-09-30 13F BIOHAVEN PHARMACTL HLDG CO L COM G11196105 0 -67 -100.00 0 -100.00
2017-08-11 2017-06-30 13F BIOHAVEN PHARMACTL HLDG CO L COM G11196105 67 67 2 0.0000
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-08-11 2025-06-30 13F BIOHAVEN COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2025-05-12 2025-03-31 13F BIOHAVEN COM Put 50,000 1,202 n/a n/a n/a
2022-08-10 2022-06-30 13F BIOHAVEN PHARMACTL HLDG CO L COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-05-12 2022-03-31 13F BIOHAVEN PHARMACTL HLDG CO L COM Put 9,000 1,067 n/a n/a n/a
2020-05-12 2020-03-31 13F BIOHAVEN PHARMACTL HLDG CO L COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-02-12 2019-12-31 13F BIOHAVEN PHARMACTL HLDG CO L COM Put 30,000 1,633 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.